Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019
Open Access
- 3 October 2021
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 16 (1) , 151-158
Abstract
Background: Respiratory syncytial virus (RSV) infections are common in adults, but data describing the cost of RSV‐associated hospitalization are lacking due to inconsistency in diagnostic coding and incomplete case ascertainment. We evaluated costs of RSV‐associated hospitalization in adult patients with laboratory‐confirmed, community‐onset RSV.Methods: We included adults ≥ 18 years of age admitted to three hospital systems in New York during two RSV seasons who were RSV‐positive by polymerase chain reaction (PCR) and had more than or equal to two acute respiratory infection symptoms or exacerbation of underlying cardiopulmonary disease. We abstracted costs from hospital finance systems or converted hospital charges to cost using cost‐charge ratios. We converted cost into 2020 US dollars and extrapolated to the United States. We used a generalized linear model to determine predictors of hospitalization cost, stratified by admission to intensive care units (ICU).Results: Cost data were available for 79% (601/756) of eligible patients. The mean total cost of hospitalization was $8403 (CI95 $7240–$9741). The highest costs were those attributed to ICU services $7885 (CI95 $5877–$10,240), whereas the lowest were radiology $324 (CI95 $275–$376). Other than longer length of stay, predictors of higher cost included having chronic liver disease (odds ratio [OR] 1.38 [CI95 1.05–1.80]) for patients without ICU admission and antibiotic use (OR 1.49 [CI95 1.10–2.03]) for patients with ICU admission. The annual US cost was estimated to be $1.2 (CI95 0.9–1.4) billion.Conclusion: The economic burden of RSV hospitalization of adults ≥ 18 years of age in the United States is substantial. RSV vaccine programs may be useful in reducing this economic burden.Keywords
Funding Information
- Merck Sharp and Dohme United Kingdom
This publication has 22 references indexed in Scilit:
- The Cost of Obesity for Nonbariatric Inpatient Operative Procedures in the United StatesAnnals of Surgery, 2013
- Comparing Methodologies for the Allocation of Overhead and Capital Costs to Hospital ServicesValue in Health, 2009
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Critical Care Medicine, 2008
- The Costs of Nosocomial InfectionsMedical Care, 2008
- DIAGNOSTIC VIROLOGY PRACTICES FOR RESPIRATORY SYNCYTIAL VIRUS AND INFLUENZA VIRUS AMONG CHILDREN IN THE HOSPITAL SETTING: A NATIONAL SURVEYThe Pediatric Infectious Disease Journal, 2007
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Respiratory Syncytial Virus Pneumonia among the Elderly: An Assessment of Disease BurdenThe Journal of Infectious Diseases, 1999
- Acute respiratory illness in the community. Frequency of illness and the agents involvedEpidemiology and Infection, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Confidence Intervals for the Product of Two Binomial ParametersJournal of the American Statistical Association, 1957